Home › Myasthenia Gravis › Oregon
Myasthenia Gravis clinical trials in Oregon
8 studies for Myasthenia Gravis are looking for participants at sites in Oregon.
Cities in Oregon
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
- University of Oregon, Portland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT06414954RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Oregon Health & Science University, Portland
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Aug 13, 2026 · NCT06359041Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1031, Eugene
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Jul 30, 2026 · NCT07039916KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Oregon Health & Science University, Portland
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06193889A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- Empower Clinical Research, Tigard
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT06456580A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Oregon Health & Science University (OHSU), Portland
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 25, 2026 · NCT06626919A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Oregon Health and Science University, Portland
- University of Colorado Hospital, Portland
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06298565The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
- OHSU, Portland
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 11, 2025 · NCT05564936From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.